Chemical industry – Page 5
-
BusinessBiogen to cut 1000 more jobs by 2025
Biotech giant has also agreed to buy Reata Pharmaceuticals for $7.3 billion
-
BusinessIllumina’s Grail quest results in epic fine
EU and US competition authorities object to firms completing merger without approval
-
ArticleMimicking our eyes’ sun protection
Sóliome is developing sunscreens based on natural UV-filtering peptides
-
OpinionWho knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
BusinessJ&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
BusinessRevolutionising RSV prevention
New vaccines and a long-acting antibody aim to protect older adults and babies from respiratory syncytial virus
-
NewsRepercussions of Bhopal disaster found to echo on down through generations
Women pregnant in the city at the time of deadly accident gave birth to children who have higher risk of cancer
-
BusinessEnvironmental groups claim US herbicide reapprovals were illegal
Lawsuit says Environmental Protection Agency ignored serious risks with 2,4-D-containing Enlist products
-
ResearchAI can suggest Covid-19 antivirals from protein sequence alone
IBM model can also find molecules that bind at different sites on target proteins
-
BusinessRecycling plastic with enzymes
Carbios can return even hard-to-recycle polyester fibres and textiles to their constituent monomers
-
FeatureFixing nitrogen fixing
Green ammonia promises a more sustainable future. Jamie Durrani talks to the researchers aiming to revolutionise the production of crucial fertiliser
-
BusinessBio-based plastics compete for space
From drop-in replacements to new polymers, what role will renewable materials play in a sustainable future?
-
OpinionBringing drug manufacturing back home
Pharmaceutical supply chains are international, complex and opaque. Is there a better way?
-
BusinessUK diverges from EU rules with cosmetics animal testing ban
UK will no longer allow Reach-required animal tests intended to prove worker safety
-
BusinessChemical firms kept data on PFAS health hazards secret
Documents suggest that DuPont and 3M had evidence of PFAS toxicity but suppressed the findings
-
ResearchColour-changing liquids could flag cold chain breaches for medicines
Device offers simple and reliable monitoring with no electronic waste
-
BusinessUS trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
-
BusinessThe diabetes drugs aiming to aid weight loss
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
-
BusinessUS supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
OpinionRegulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards